Subscribe
shutterstock_549156772_ken_wolter
Ken Wolter / Shutterstock.com
25 March 2021AmericasAlex Baldwin

Snyders revives patent claims against St Jude Medical

Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Federal Circuit resuscitates Snyder’s heart valve patent
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.
Americas
Medtronic seeks to settle patent dispute with Snyder
16 May 2017   Medtronic has filed a motion to stay all deadlines and a notice of settlement in a patent dispute with medical device company Snyder Heart Valve.
Medtech
Federal Circuit hands victory to Snyders over heart valve patent
7 October 2021   The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Medtech
Federal Circuit hands victory to Snyders over heart valve patent
7 October 2021   The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories.
Americas
Medtronic seeks to settle patent dispute with Snyder
16 May 2017   Medtronic has filed a motion to stay all deadlines and a notice of settlement in a patent dispute with medical device company Snyder Heart Valve.
Americas
Federal Circuit resuscitates Snyder’s heart valve patent
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

More on this story

Medtech
Federal Circuit hands victory to Snyders over heart valve patent
7 October 2021   The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories.
Americas
Medtronic seeks to settle patent dispute with Snyder
16 May 2017   Medtronic has filed a motion to stay all deadlines and a notice of settlement in a patent dispute with medical device company Snyder Heart Valve.
Americas
Federal Circuit resuscitates Snyder’s heart valve patent
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent